( NASDAQ-NMS:LMNX )

News from Luminex Corporation A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages.

Latest

Feb 06, 2017, 16:05 ET Luminex Corporation Reports Fourth Quarter And Full Year 2016 Results

Luminex Corporation (NASDAQ:LMNX) today announced financial results for the fourth quarter and full year 2016 ended December 31, 2016. Financial...


Jan 09, 2017, 08:30 ET Luminex Announces Preliminary Revenue for Fourth Quarter 2016 and Issues 2017 Revenue Guidance; To Present at 35th Annual J.P. Morgan Healthcare Conference

Luminex Corporation (NASDAQ: LMNX) today announced that it expects revenues in the fourth quarter of 2016 to be approximately $72 million and...


Jan 04, 2017, 08:00 ET Luminex Corporation Receives FDA Clearance for ARIES® GBS Assay

Luminex Corporation (NASDAQ: LMNX) today announced that it has received FDA clearance for the ARIES® Group B Streptococcus (GBS) Assay for...


Dec 05, 2016, 08:00 ET Luminex wins R&D 100 Award for ARIES Systems

Luminex Corporation (NASDAQ: LMNX) today announced that the company was awarded the prestigious R&D 100 Award for its ARIES® Systems at the...


Nov 17, 2016, 14:30 ET ARIES System und Flu A/B & RSV Assay von Erasmus MC in neuer Publikation evaluiert

Publikation im Journal of Clinical Virology demonstriert Effektivität und einfache Handhabung für Routinetests Die Luminex Corporation...


Nov 17, 2016, 12:39 ET Le centre médical Érasme évalue le système ARIES et le kit de dépistage de la grippe A/B et du RSV dans une nouvelle publication

Le Journal of Clinical Virology démontre l'efficacité et la facilité d'utilisation pour les tests de routine Luminex Corporation (NASDAQ :...


Nov 17, 2016, 08:00 ET ARIES System and Flu A/B & RSV Assay Evaluated by Erasmus MC in New Publication

Luminex Corporation (NASDAQ: LMNX) today announced that the internationally renowned Department of Viroscience at Erasmus Medical Center in...


Nov 07, 2016, 16:05 ET Luminex Corporation To Present At The 28th Annual Piper Jaffray Healthcare Conference

Luminex Corporation (NASDAQ: LMNX) today announced that management will present at the 28th Annual Piper Jaffray Healthcare Conference to be...


Oct 31, 2016, 16:05 ET Luminex Corporation Reports Third Quarter 2016 Results; Raises Full Year Guidance

Luminex Corporation (NASDAQ:LMNX) today announced financial results for the third quarter ended September 30, 2016. Financial and operating...


Oct 11, 2016, 16:05 ET Luminex Corporation Third Quarter Earnings Release Scheduled for October 31, 2016

Luminex Corporation (NASDAQ: LMNX) today announced that it expects to report results for the third quarter ended September 30, 2016 on Monday,...


Aug 08, 2016, 08:30 ET Luminex Corporation Receives FDA Emergency Use Authorization for Zika Virus Molecular Detection Assay

 Luminex Corporation (NASDAQ: LMNX) today announced that it has received Emergency Use Authorization (EUA) from the U.S. Food and Drug...


Aug 03, 2016, 08:30 ET Luminex Corporation Receives FDA Clearance for New Molecular Test for Identification and Differentiation of Influenza A/B and Respiratory Syncytial Virus

 Luminex Corporation (NASDAQ: LMNX) today announced that it has received FDA clearance for the ARIES® Flu A/B & RSV Assay. This...


Jul 28, 2016, 16:05 ET Luminex Corporation Reports Second Quarter 2016 Results

 Luminex Corporation (NASDAQ:LMNX) today announced financial results for the second quarter ended June 30, 2016.  Financial and operating...


Jul 20, 2016, 08:30 ET Luminex Corporation Second Quarter Earnings Release Scheduled for July 28; Revision to Conference Call Date/Time

Luminex Corporation (NASDAQ: LMNX) today announced that it will now hold a conference call to discuss the second quarter operating highlights and...


Jul 08, 2016, 08:30 ET Luminex Corporation Second Quarter Earnings Release Scheduled for July 28, 2016

 Luminex Corporation (NASDAQ: LMNX) today announced that it expects to report results for the second quarter ended June 30, 2016 on Thursday,...


Jul 06, 2016, 14:38 ET Luminex Corporation obtient l'autorisation de la FDA et le marquage CE-DIV pour son système ARIES M1

L'extension de la plateforme ARIES offre des avantages significatifs aux laboratoires cliniques présentant des exigences de débit...


Jul 06, 2016, 11:37 ET Luminex Corporation recibe aprobación FDA y marca CE-IVD para el sistema ARIES M1

La extensión de la plataforma ARIES proporciona los beneficios significativos de ARIES para laboratorios clínicos con menores...


Jul 06, 2016, 07:00 ET Luminex Corporation erhält die FDA-Zulassung und CE-IVD-Kennzeichnung für das ARIES M1 System

Die Erweiterung der ARIES-Plattform bietet die nennenswerten Vorteile von ARIES auch für klinische Labors mit geringeren...


Jul 06, 2016, 07:00 ET Luminex Corporation Receives FDA Clearance and CE-IVD Mark for the ARIES M1 System

 Luminex Corporation (NASDAQ: LMNX) today announced it has received FDA clearance and CE-IVD marking for a new in vitro diagnostic system, the...


Jun 30, 2016, 08:55 ET Luminex Corporation Completes Acquisition of Nanosphere, Inc.

 Luminex Corporation (NASDAQ: LMNX) today announced that Luminex has completed its previously announced acquisition of Nanosphere, Inc....


Jun 22, 2016, 16:05 ET Luminex Corporation To Present At Cantor Fitzgerald's 2nd Annual Healthcare Conference

 Luminex Corporation (NASDAQ: LMNX) today announced that management will present at Cantor Fitzgerald's 2nd Annual Healthcare Conference to be...


Jun 02, 2016, 06:00 ET Luminex Corporation Announces Commencement of Tender Offer for All Outstanding Shares of Nanosphere, Inc. Common Stock

 Luminex Corporation (NASDAQ: LMNX) announced today that its wholly-owned subsidiary Commodore Acquisition, Inc. has commenced its...


Jun 01, 2016, 13:48 ET Luminex Corporation obtient le marquage CE-IVD pour l'essai ARIES relatif au virus grippal A/B et au VRS

 Luminex Corporation (NASDAQ : LMNX) a annoncé aujourd'hui que la société avait obtenu le statut CE-IVD en vertu de la...


Jun 01, 2016, 09:15 ET Luminex Corporation erhält CE-IVD-Kennzeichnung für das ARIES Flu A/B & RSV Assay

 Luminex Corporation (NASDAQ: LMNX) gab heute bekannt, dass man den CE-IVD-Satus für das ARIES® Flu A/B & RSV Assay...


Jun 01, 2016, 09:15 ET Luminex Corporation Receives CE-IVD Mark for ARIES Flu A/B & RSV Assay

 Luminex Corporation (NASDAQ: LMNX) today announced that it has received CE-IVD  status under the European Directive on In Vitro...